We are live on
!
Find out more
LNAI
Lunai Bioworks
LNAI
LNAI
41 hedge funds and large institutions have $19.2M invested in Lunai Bioworks in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
217% more call options, than puts
Call options by funds: $133K | Put options by funds: $42K
117% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 6
106% more capital invested
Capital invested by funds: $9.31M → $19.2M (+$9.89M)
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
14% more funds holding
Funds holding: 36 → 41 (+5)
0.01% more ownership
Funds ownership: 0.05% → 0.06% (+0.01%)
Holders
41
Holders Change
+5
Holders Change %
+13.89%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
13
Reduced
6
Closed
10
Calls
$133K
Puts
$42K
Net Calls
+$91K
Net Calls Change
+$9K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.9M |
| 2 |
Goldman Sachs
New York
|
+$989K |
| 3 |
Millennium Management
New York
|
+$564K |
| 4 |
Citigroup
New York
|
+$460K |
| 5 |
Man Group
London,
United Kingdom
|
+$364K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1.18M |
| 2 |
6CM
683 Capital Management
New York
|
-$234K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$150K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$118K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$81.2K |
